LYMPHEXIL

Serial Number 76696972
606

Registration Progress

Application Filed
Apr 20, 2009
Under Examination
Dec 8, 2009
Approved for Publication
Aug 26, 2009
Published for Opposition
Sep 15, 2009
Registered

Trademark Image

LYMPHEXIL

Basic Information

Serial Number
76696972
Filing Date
April 20, 2009
Published for Opposition
September 15, 2009
Abandonment Date
July 12, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 12, 2010
Classes
005

Rights Holder

Royds Pharmaceuticals, Inc.

03
Address
4365 Route 1 South, Suite 101
Princeton, NJ 08540

Ownership History

Royds Pharmaceuticals, Inc.

Original Applicant
03
Princeton, NJ

Royds Pharmaceuticals, Inc.

Owner at Publication
03
Princeton, NJ

Legal Representation

Attorney
KENNETH WATOV

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Jul 12, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 12, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 8, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 15, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 26, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Aug 12, 2009 ALIE A ASSIGNED TO LIE Loading...
Aug 12, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 4, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 31, 2009 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 31, 2009 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 31, 2009 CNEA O EXAMINERS AMENDMENT MAILED Loading...
Jul 20, 2009 CNRT F NON-FINAL ACTION MAILED Loading...
Jul 17, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 10, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 28, 2009 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 23, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, an injectable pharmaceutical for the sclerosing treatment of lymphomatous malformations
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005